English

REGEN BIOLOGICS INC

EDGAR

Quarterly report amendment (10-Q/A) · filed 2010-01-08

70 filing records in this dataset, filed from 1996-08-09 to 2010-01-08. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

409 thousand USD

2009-06-30 · USD

Exact inputs and evidence

Revenue: 409000 USD Source

Operating margin

-995.35%

2009-06-30 · %

Exact inputs and evidence

Operating Income: -4071000 USD Source
Revenue: 409000 USD Source

Operating cash flow

-3.65 million USD

2009-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -6432000 USD Source
Operating Cash Flow: -2787000 USD Source

Free cash flow

-3.66 million USD

2009-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -6432000 USD Source
Operating Cash Flow: -2787000 USD Source
Capital Expenditure: 55000 USD Source
Capital Expenditure: 42000 USD Source

Cash and cash equivalents: 2.47 million USD 2009-06-30 Source
Exact value

2474000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-14.9 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Net income: -7002000 USD · 2008-01-01 – 2008-09-30 Source
Net income: -4629000 USD · 2008-01-01 – 2008-06-30 Source
Net income: -9951000 USD · 2008-01-01 – 2008-12-31 Source
Net income: -7002000 USD · 2008-01-01 – 2008-09-30 Source
Net income: -5374000 USD · 2009-01-01 – 2009-03-31 Source
Net income: -4164000 USD · 2009-04-01 – 2009-06-30 Source

Operating cash flow

-9.68 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Operating cash flow: -5115000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -3527000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -6775000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -5115000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -2787000 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -6432000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: -2787000 USD · 2009-01-01 – 2009-03-31 Source

Capital expenditure

66 thousand USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Capital expenditure: 18000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 18000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 29000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 18000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 55000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-03-31 Source

Free cash flow

-9.75 million USD

2008-07-01 – 2009-06-30

Exact inputs and evidence

Operating cash flow: -5115000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -3527000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: -6775000 USD · 2008-01-01 – 2008-12-31 Source
Operating cash flow: -5115000 USD · 2008-01-01 – 2008-09-30 Source
Operating cash flow: -2787000 USD · 2009-01-01 – 2009-03-31 Source
Operating cash flow: -6432000 USD · 2009-01-01 – 2009-06-30 Source
Operating cash flow: -2787000 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 18000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 18000 USD · 2008-01-01 – 2008-06-30 Source
Capital expenditure: 29000 USD · 2008-01-01 – 2008-12-31 Source
Capital expenditure: 18000 USD · 2008-01-01 – 2008-09-30 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-03-31 Source
Capital expenditure: 55000 USD · 2009-01-01 – 2009-06-30 Source
Capital expenditure: 42000 USD · 2009-01-01 – 2009-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-01-08.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2008-12-31
Operating income: 11 of 11 periods available· newest 2008-12-31
Net income: 11 of 11 periods available· newest 2008-12-31
Operating cash flow: 11 of 11 periods available· newest 2008-12-31
Capital expenditure: 11 of 11 periods available· newest 2008-12-31
Total assets: 11 of 11 periods available· newest 2008-12-31
Total liabilities: 11 of 11 periods available· newest 2008-12-31
Current assets: 11 of 11 periods available· newest 2008-12-31
Current liabilities: 11 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+39.4%

Prior period

USD 986,000

2007-01-01 – 2007-12-31
Current period

USD 1.37 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

1374000 − 986000 = 388000 USD

986000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
1374000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Year-over-year change in Revenue: 388000 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1374000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#7942 Input fundies:Revenue: 986000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#7942
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 426,000

Prior period

−USD 10.38 million

2007-01-01 – 2007-12-31
Current period

−USD 9.95 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-9951000 − -10377000 = 426000 USD

-10377000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-9951000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Year-over-year change in Net income: 426000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -9951000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10391 Input fundies:NetIncome: -10377000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10391
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 2.38 million

Prior period

−USD 9.16 million

2007-01-01 – 2007-12-31
Current period

−USD 6.78 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-6775000 − -9158000 = 2383000 USD

-9158000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-6775000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Year-over-year change in Operating cash flow: 2383000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -6775000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10755 Input fundies:OperatingCashFlow: -9158000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10755
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-83%

Prior period

USD 171,000

2007-01-01 – 2007-12-31
Current period

USD 29,000

2008-01-01 – 2008-12-31

Exact inputs and evidence

29000 − 171000 = -142000 USD

171000 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
29000 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Year-over-year change in Capital expenditure: -142000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 29000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10812 Input fundies:CapitalExpenditure: 171000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10812
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 1.37 million 100% of revenue
Operating costs Derived USD 10.52 million 765% of revenue
Operating income −USD 9.14 million −665% of revenue
Tax, interest and other Derived USD 810,000 59% of revenue
Net income −USD 9.95 million −724% of revenue

Cash

Operating cash flow −USD 6.78 million −493% of revenue
Capital expenditure USD 29,000 2.1% of revenue
Free cash flow Derived −USD 6.8 million −495% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1999 Not shown: operating income or net income is not reported.
2000 Operating loss: operating costs were 653% of revenue.
2001 Operating loss: operating costs were 1,148% of revenue.
2002 Operating loss: operating costs were 1,115% of revenue.
2003 Operating loss: operating costs were 2,051% of revenue.
2004 Operating loss: operating costs were 1,530% of revenue.
2005 Operating loss: operating costs were 2,182% of revenue.
2006 Operating loss: operating costs were 2,242% of revenue.
2007 Operating loss: operating costs were 1,145% of revenue.
2008 Operating loss: operating costs were 765% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1999 1999-01-01 – 1999-12-31	0	-1055000 Derived	1055000	-296000 Derived	1351000	-384000 Derived	Source 1999-01-01 – 1999-12-31: 0 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 1055000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 1351000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -312000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 72000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	972000	6348000 Derived	-5376000	-147000 Derived	-5229000	-3693000 Derived	Source 2000-01-01 – 2000-12-31: 972000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -5376000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -5229000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -3677000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 16000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	490000	5626000 Derived	-5136000	-806000 Derived	-4330000	-2430000 Derived	Source 2001-01-01 – 2001-12-31: 490000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -5136000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -4330000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -2416000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 14000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	781000	8708000 Derived	-7927000	2024000 Derived	-9951000	-4743000 Derived	Source 2002-01-01 – 2002-12-31: 781000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -7927000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -9951000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -4737000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 6000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	293000	6008000 Derived	-5715000	274000 Derived	-5989000	-4715000 Derived	Source 2003-01-01 – 2003-12-31: 293000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -5715000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -5989000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -4671000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 44000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	504000	7709000 Derived	-7205000	-4000 Derived	-7201000	-6131000 Derived	Source 2004-01-01 – 2004-12-31: 504000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -7205000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -7201000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -6112000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 19000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	570000	12438000 Derived	-11868000	-137000 Derived	-11731000	-9848000 Derived	Source 2005-01-01 – 2005-12-31: 570000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -11868000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -11731000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -9723000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 125000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	586000	13138000 Derived	-12552000	105000 Derived	-12657000	-12421000 Derived	Source 2006-01-01 – 2006-12-31: 586000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -12552000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -12657000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -12239000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 182000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	986000	11287000 Derived	-10301000	76000 Derived	-10377000	-9329000 Derived	Source 2007-01-01 – 2007-12-31: 986000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -10301000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -10377000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -9158000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 171000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	1374000	10515000 Derived	-9141000	810000 Derived	-9951000	-6804000 Derived	Source 2008-01-01 – 2008-12-31: 1374000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -9141000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -9951000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -6775000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 29000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.4M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Revenue	0	Revenue: 0 Open source
20002000-12-31	Revenue	972000	Revenue: 972000 Open source
20012001-12-31	Revenue	490000	Revenue: 490000 Open source
20022002-12-31	Revenue	781000	Revenue: 781000 Open source
20032003-12-31	Revenue	293000	Revenue: 293000 Open source
20042004-12-31	Revenue	504000	Revenue: 504000 Open source
20052005-12-31	Revenue	570000	Revenue: 570000 Open source
20062006-12-31	Revenue	586000	Revenue: 586000 Open source
20072007-12-31	Revenue	986000	Revenue: 986000 Open source
20082008-12-31	Revenue	1374000	Revenue: 1374000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

39.4% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 10206000 Open source
20002000-12-31	Year over year	No prior comparable period	Revenue: 972000 Open source Revenue: 0 Open source
20012001-12-31	Year over year	-49.6%	Revenue: 490000 Open source Revenue: 972000 Open source
20022002-12-31	Year over year	59.4%	Revenue: 781000 Open source Revenue: 490000 Open source
20032003-12-31	Year over year	-62.5%	Revenue: 293000 Open source Revenue: 781000 Open source
20042004-12-31	Year over year	72%	Revenue: 504000 Open source Revenue: 293000 Open source
20052005-12-31	Year over year	13.1%	Revenue: 570000 Open source Revenue: 504000 Open source
20062006-12-31	Year over year	2.8%	Revenue: 586000 Open source Revenue: 570000 Open source
20072007-12-31	Year over year	68.3%	Revenue: 986000 Open source Revenue: 586000 Open source
20082008-12-31	Year over year	39.4%	Revenue: 1374000 Open source Revenue: 986000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -665.3% 2008

Net margin -724.2% 2008

Free cash flow margin -495.2% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Operating margin	Not reported	Operating Income: 1055000 Open source Revenue: 0 Open source
20002000-12-31	Operating margin	-553.1%	Operating Income: -5376000 Open source Revenue: 972000 Open source
20012001-12-31	Operating margin	-1,048.2%	Operating Income: -5136000 Open source Revenue: 490000 Open source
20022002-12-31	Operating margin	-1,015%	Operating Income: -7927000 Open source Revenue: 781000 Open source
20032003-12-31	Operating margin	-1,950.5%	Operating Income: -5715000 Open source Revenue: 293000 Open source
20042004-12-31	Operating margin	-1,429.6%	Operating Income: -7205000 Open source Revenue: 504000 Open source
20052005-12-31	Operating margin	-2,082.1%	Operating Income: -11868000 Open source Revenue: 570000 Open source
20062006-12-31	Operating margin	-2,142%	Operating Income: -12552000 Open source Revenue: 586000 Open source
20072007-12-31	Operating margin	-1,044.7%	Operating Income: -10301000 Open source Revenue: 986000 Open source
20082008-12-31	Operating margin	-665.3%	Operating Income: -9141000 Open source Revenue: 1374000 Open source
19991999-12-31	Net margin	Not reported	Net Income: 1351000 Open source Revenue: 0 Open source
20002000-12-31	Net margin	-538%	Net Income: -5229000 Open source Revenue: 972000 Open source
20012001-12-31	Net margin	-883.7%	Net Income: -4330000 Open source Revenue: 490000 Open source
20022002-12-31	Net margin	-1,274.1%	Net Income: -9951000 Open source Revenue: 781000 Open source
20032003-12-31	Net margin	-2,044%	Net Income: -5989000 Open source Revenue: 293000 Open source
20042004-12-31	Net margin	-1,428.8%	Net Income: -7201000 Open source Revenue: 504000 Open source
20052005-12-31	Net margin	-2,058.1%	Net Income: -11731000 Open source Revenue: 570000 Open source
20062006-12-31	Net margin	-2,159.9%	Net Income: -12657000 Open source Revenue: 586000 Open source
20072007-12-31	Net margin	-1,052.4%	Net Income: -10377000 Open source Revenue: 986000 Open source
20082008-12-31	Net margin	-724.2%	Net Income: -9951000 Open source Revenue: 1374000 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -312000 Open source Capital Expenditure: 72000 Open source
20002000-12-31	Free cash flow margin	-379.9%	Revenue: 972000 Open source Operating Cash Flow: -3677000 Open source Capital Expenditure: 16000 Open source
20012001-12-31	Free cash flow margin	-495.9%	Revenue: 490000 Open source Operating Cash Flow: -2416000 Open source Capital Expenditure: 14000 Open source
20022002-12-31	Free cash flow margin	-607.3%	Revenue: 781000 Open source Operating Cash Flow: -4737000 Open source Capital Expenditure: 6000 Open source
20032003-12-31	Free cash flow margin	-1,609.2%	Revenue: 293000 Open source Operating Cash Flow: -4671000 Open source Capital Expenditure: 44000 Open source
20042004-12-31	Free cash flow margin	-1,216.5%	Revenue: 504000 Open source Operating Cash Flow: -6112000 Open source Capital Expenditure: 19000 Open source
20052005-12-31	Free cash flow margin	-1,727.7%	Revenue: 570000 Open source Operating Cash Flow: -9723000 Open source Capital Expenditure: 125000 Open source
20062006-12-31	Free cash flow margin	-2,119.6%	Revenue: 586000 Open source Operating Cash Flow: -12239000 Open source Capital Expenditure: 182000 Open source
20072007-12-31	Free cash flow margin	-946.1%	Revenue: 986000 Open source Operating Cash Flow: -9158000 Open source Capital Expenditure: 171000 Open source
20082008-12-31	Free cash flow margin	-495.2%	Revenue: 1374000 Open source Operating Cash Flow: -6775000 Open source Capital Expenditure: 29000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -6.8M 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Operating cash flow	-312000	Operating Cash Flow: -312000 Open source
20002000-12-31	Operating cash flow	-3677000	Operating Cash Flow: -3677000 Open source
20012001-12-31	Operating cash flow	-2416000	Operating Cash Flow: -2416000 Open source
20022002-12-31	Operating cash flow	-4737000	Operating Cash Flow: -4737000 Open source
20032003-12-31	Operating cash flow	-4671000	Operating Cash Flow: -4671000 Open source
20042004-12-31	Operating cash flow	-6112000	Operating Cash Flow: -6112000 Open source
20052005-12-31	Operating cash flow	-9723000	Operating Cash Flow: -9723000 Open source
20062006-12-31	Operating cash flow	-12239000	Operating Cash Flow: -12239000 Open source
20072007-12-31	Operating cash flow	-9158000	Operating Cash Flow: -9158000 Open source
20082008-12-31	Operating cash flow	-6775000	Operating Cash Flow: -6775000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.8M 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19991999-12-31	Free cash flow	-384000	Operating Cash Flow: -312000 Open source Capital Expenditure: 72000 Open source
20002000-12-31	Free cash flow	-3693000	Operating Cash Flow: -3677000 Open source Capital Expenditure: 16000 Open source
20012001-12-31	Free cash flow	-2430000	Operating Cash Flow: -2416000 Open source Capital Expenditure: 14000 Open source
20022002-12-31	Free cash flow	-4743000	Operating Cash Flow: -4737000 Open source Capital Expenditure: 6000 Open source
20032003-12-31	Free cash flow	-4715000	Operating Cash Flow: -4671000 Open source Capital Expenditure: 44000 Open source
20042004-12-31	Free cash flow	-6131000	Operating Cash Flow: -6112000 Open source Capital Expenditure: 19000 Open source
20052005-12-31	Free cash flow	-9848000	Operating Cash Flow: -9723000 Open source Capital Expenditure: 125000 Open source
20062006-12-31	Free cash flow	-12421000	Operating Cash Flow: -12239000 Open source Capital Expenditure: 182000 Open source
20072007-12-31	Free cash flow	-9329000	Operating Cash Flow: -9158000 Open source Capital Expenditure: 171000 Open source
20082008-12-31	Free cash flow	-6804000	Operating Cash Flow: -6775000 Open source Capital Expenditure: 29000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

532.5% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Liabilities / assets	55.4%	Total Liabilities: 6353000 Open source Total Assets: 11466000 Open source
20002000-12-31	Liabilities / assets	91.1%	Total Liabilities: 4957000 Open source Total Assets: 5442000 Open source
20012001-12-31	Liabilities / assets	755.5%	Total Liabilities: 8922000 Open source Total Assets: 1181000 Open source
20022002-12-31	Liabilities / assets	179.5%	Total Liabilities: 7587000 Open source Total Assets: 4226000 Open source
20032003-12-31	Liabilities / assets	90.2%	Total Liabilities: 8146000 Open source Total Assets: 9029000 Open source
20042004-12-31	Liabilities / assets	65.6%	Total Liabilities: 8353000 Open source Total Assets: 12724000 Open source
20052005-12-31	Liabilities / assets	69.4%	Total Liabilities: 10088000 Open source Total Assets: 14543000 Open source
20062006-12-31	Liabilities / assets	101.6%	Total Liabilities: 9175000 Open source Total Assets: 9031000 Open source
20072007-12-31	Liabilities / assets	164.4%	Total Liabilities: 9046000 Open source Total Assets: 5502000 Open source
20082008-12-31	Liabilities / assets	532.5%	Total Liabilities: 12199000 Open source Total Assets: 2291000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.15× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19991999-12-31	Current assets / current liabilities	1.55×	Current Assets: 9753000 Open source Current Liabilities: 6305000 Open source
20002000-12-31	Current assets / current liabilities	1.11×	Current Assets: 5442000 Open source Current Liabilities: 4892000 Open source
20012001-12-31	Current assets / current liabilities	1.42×	Current Assets: 780000 Open source Current Liabilities: 550000 Open source
20022002-12-31	Current assets / current liabilities	5.87×	Current Assets: 3916000 Open source Current Liabilities: 667000 Open source
20032003-12-31	Current assets / current liabilities	8.99×	Current Assets: 8797000 Open source Current Liabilities: 979000 Open source
20042004-12-31	Current assets / current liabilities	10.51×	Current Assets: 12546000 Open source Current Liabilities: 1194000 Open source
20052005-12-31	Current assets / current liabilities	5.29×	Current Assets: 13992000 Open source Current Liabilities: 2645000 Open source
20062006-12-31	Current assets / current liabilities	6.4×	Current Assets: 8569000 Open source Current Liabilities: 1338000 Open source
20072007-12-31	Current assets / current liabilities	7.62×	Current Assets: 4991000 Open source Current Liabilities: 655000 Open source
20082008-12-31	Current assets / current liabilities	0.15×	Current Assets: 1860000 Open source Current Liabilities: 12003000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1999 1999-01-01 – 1999-12-31	USD 1.35 million Exact value Exact value: 1351000 USD 1999-01-01 – 1999-12-31: 1351000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 1999-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: 1351000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1351000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-02-001717.txt#855 The citation records this snapshot. The page link may show a newer release later.	−USD 312,000 Exact value Exact value: -312000 USD 1999-01-01 – 1999-12-31: -312000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 1999-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -312000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -312000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-02-001717.txt#1037 The citation records this snapshot. The page link may show a newer release later.	USD 72,000 Exact value Exact value: 72000 USD 1999-01-01 – 1999-12-31: 72000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 1999-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 72000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 72000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-01-001185.txt#1765 The citation records this snapshot. The page link may show a newer release later.	−USD 384,000 Calculation and evidence -312000 − 72000 USD Exact free cash flow: -384000 USD 1999-01-01 – 1999-12-31: -312000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 72000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 1999-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -384000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -312000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-02-001717.txt#1037 Input fundies:CapitalExpenditure: 72000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-01-001185.txt#1765 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 5.23 million Exact value Exact value: -5229000 USD 2000-01-01 – 2000-12-31: -5229000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2000-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -5229000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5229000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-03-001306.txt#14277 The citation records this snapshot. The page link may show a newer release later.	−USD 3.68 million Exact value Exact value: -3677000 USD 2000-01-01 – 2000-12-31: -3677000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2000-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -3677000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3677000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-03-001306.txt#14655 The citation records this snapshot. The page link may show a newer release later.	USD 16,000 Exact value Exact value: 16000 USD 2000-01-01 – 2000-12-31: 16000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2000-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 16000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-03-001306.txt#14702 The citation records this snapshot. The page link may show a newer release later.	−USD 3.69 million Calculation and evidence -3677000 − 16000 USD Exact free cash flow: -3693000 USD 2000-01-01 – 2000-12-31: -3677000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 16000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2000-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -3693000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3677000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-03-001306.txt#14655 Input fundies:CapitalExpenditure: 16000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-03-001306.txt#14702 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 4.33 million Exact value Exact value: -4330000 USD 2001-01-01 – 2001-12-31: -4330000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2001-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -4330000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4330000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-04-002426.txt#20016 The citation records this snapshot. The page link may show a newer release later.	−USD 2.42 million Exact value Exact value: -2416000 USD 2001-01-01 – 2001-12-31: -2416000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2001-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -2416000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2416000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-04-002426.txt#20367 The citation records this snapshot. The page link may show a newer release later.	USD 14,000 Exact value Exact value: 14000 USD 2001-01-01 – 2001-12-31: 14000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2001-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 14000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-04-002426.txt#20414 The citation records this snapshot. The page link may show a newer release later.	−USD 2.43 million Calculation and evidence -2416000 − 14000 USD Exact free cash flow: -2430000 USD 2001-01-01 – 2001-12-31: -2416000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 14000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2001-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -2430000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2416000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-04-002426.txt#20367 Input fundies:CapitalExpenditure: 14000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-04-002426.txt#20414 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 9.95 million Exact value Exact value: -9951000 USD 2002-01-01 – 2002-12-31: -9951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2002-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -9951000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9951000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-05-001316.txt#21071 The citation records this snapshot. The page link may show a newer release later.	−USD 4.74 million Exact value Exact value: -4737000 USD 2002-01-01 – 2002-12-31: -4737000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2002-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -4737000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4737000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-05-001316.txt#21422 The citation records this snapshot. The page link may show a newer release later.	USD 6,000 Exact value Exact value: 6000 USD 2002-01-01 – 2002-12-31: 6000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2002-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 6000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-05-001316.txt#21490 The citation records this snapshot. The page link may show a newer release later.	−USD 4.74 million Calculation and evidence -4737000 − 6000 USD Exact free cash flow: -4743000 USD 2002-01-01 – 2002-12-31: -4737000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 6000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2002-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -4743000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4737000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-05-001316.txt#21422 Input fundies:CapitalExpenditure: 6000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-05-001316.txt#21490 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 5.99 million Exact value Exact value: -5989000 USD 2003-01-01 – 2003-12-31: -5989000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2003-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -5989000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5989000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-06-005061.txt#45864 The citation records this snapshot. The page link may show a newer release later.	−USD 4.67 million Exact value Exact value: -4671000 USD 2003-01-01 – 2003-12-31: -4671000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2003-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -4671000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4671000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-06-005061.txt#46708 The citation records this snapshot. The page link may show a newer release later.	USD 44,000 Exact value Exact value: 44000 USD 2003-01-01 – 2003-12-31: 44000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2003-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 44000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-06-005061.txt#46873 The citation records this snapshot. The page link may show a newer release later.	−USD 4.72 million Calculation and evidence -4671000 − 44000 USD Exact free cash flow: -4715000 USD 2003-01-01 – 2003-12-31: -4671000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 44000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2003-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -4715000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4671000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-06-005061.txt#46708 Input fundies:CapitalExpenditure: 44000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-06-005061.txt#46873 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 7.2 million Exact value Exact value: -7201000 USD 2004-01-01 – 2004-12-31: -7201000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2004-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -7201000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7201000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#42398 The citation records this snapshot. The page link may show a newer release later.	−USD 6.11 million Exact value Exact value: -6112000 USD 2004-01-01 – 2004-12-31: -6112000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2004-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -6112000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6112000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43242 The citation records this snapshot. The page link may show a newer release later.	USD 19,000 Exact value Exact value: 19000 USD 2004-01-01 – 2004-12-31: 19000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2004-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 19000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 19000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43407 The citation records this snapshot. The page link may show a newer release later.	−USD 6.13 million Calculation and evidence -6112000 − 19000 USD Exact free cash flow: -6131000 USD 2004-01-01 – 2004-12-31: -6112000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 19000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2004-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -6131000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6112000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43242 Input fundies:CapitalExpenditure: 19000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43407 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 11.73 million Exact value Exact value: -11731000 USD 2005-01-01 – 2005-12-31: -11731000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2005-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -11731000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11731000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#42398 The citation records this snapshot. The page link may show a newer release later.	−USD 9.72 million Exact value Exact value: -9723000 USD 2005-01-01 – 2005-12-31: -9723000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2005-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -9723000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9723000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43242 The citation records this snapshot. The page link may show a newer release later.	USD 125,000 Exact value Exact value: 125000 USD 2005-01-01 – 2005-12-31: 125000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2005-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 125000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 125000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43407 The citation records this snapshot. The page link may show a newer release later.	−USD 9.85 million Calculation and evidence -9723000 − 125000 USD Exact free cash flow: -9848000 USD 2005-01-01 – 2005-12-31: -9723000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 125000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2005-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -9848000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9723000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43242 Input fundies:CapitalExpenditure: 125000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0000950133-07-001379.txt#43407 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 12.66 million Exact value Exact value: -12657000 USD 2006-01-01 – 2006-12-31: -12657000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2006-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -12657000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12657000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-08-007846.txt#17255 The citation records this snapshot. The page link may show a newer release later.	−USD 12.24 million Exact value Exact value: -12239000 USD 2006-01-01 – 2006-12-31: -12239000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2006-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -12239000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12239000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-08-007846.txt#17509 The citation records this snapshot. The page link may show a newer release later.	USD 182,000 Exact value Exact value: 182000 USD 2006-01-01 – 2006-12-31: 182000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2006-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 182000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 182000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-08-007846.txt#17545 The citation records this snapshot. The page link may show a newer release later.	−USD 12.42 million Calculation and evidence -12239000 − 182000 USD Exact free cash flow: -12421000 USD 2006-01-01 – 2006-12-31: -12239000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 182000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2006-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -12421000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12239000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-08-007846.txt#17509 Input fundies:CapitalExpenditure: 182000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-08-007846.txt#17545 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 10.38 million Exact value Exact value: -10377000 USD 2007-01-01 – 2007-12-31: -10377000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2007-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -10377000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10377000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10391 The citation records this snapshot. The page link may show a newer release later.	−USD 9.16 million Exact value Exact value: -9158000 USD 2007-01-01 – 2007-12-31: -9158000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2007-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -9158000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9158000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10755 The citation records this snapshot. The page link may show a newer release later.	USD 171,000 Exact value Exact value: 171000 USD 2007-01-01 – 2007-12-31: 171000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2007-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 171000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 171000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10812 The citation records this snapshot. The page link may show a newer release later.	−USD 9.33 million Calculation and evidence -9158000 − 171000 USD Exact free cash flow: -9329000 USD 2007-01-01 – 2007-12-31: -9158000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 171000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2007-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -9329000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9158000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10755 Input fundies:CapitalExpenditure: 171000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10812 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 9.95 million Exact value Exact value: -9951000 USD 2008-01-01 – 2008-12-31: -9951000 USD Inspect Net Income Open source Share or cite Citation for Net Income · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Net Income: -9951000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9951000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10391 The citation records this snapshot. The page link may show a newer release later.	−USD 6.78 million Exact value Exact value: -6775000 USD 2008-01-01 – 2008-12-31: -6775000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Operating Cash Flow: -6775000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6775000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10755 The citation records this snapshot. The page link may show a newer release later.	USD 29,000 Exact value Exact value: 29000 USD 2008-01-01 – 2008-12-31: 29000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Capital Expenditure: 29000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 29000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10812 The citation records this snapshot. The page link may show a newer release later.	−USD 6.8 million Calculation and evidence -6775000 − 29000 USD Exact free cash flow: -6804000 USD 2008-01-01 – 2008-12-31: -6775000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 29000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · REGEN BIOLOGICS INC · 2008-12-31 REGEN BIOLOGICS INC (edgar:883697) Free cash flow: -6804000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:28:56Z Snapshot: 6dac8659482e18656fe94a73038463dc92647c94f7c950f9680dee8ca8e8ae9d Dimensions: Consolidated View: https://fundies.io/companies/edgar/883697?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6775000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10755 Input fundies:CapitalExpenditure: 29000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/883697/0001140361-09-008027.txt#10812 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

70 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000883697, 883697, edgar:883697

Also known as APACHE MEDICAL SYSTEMS INC, AROS CORP

REGEN BIOLOGICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation